P1150: REAL WORLD DATA ON BORTEZOMIB-BASED THERAPY IN WALDENSTRÖM’S MACROGLOBULINAEMIA: EFFECTIVE EVEN IN MULTIPLY TREATED PATIENTS INCLUDING PRIOR BTK-INHIBITORS

por Uppal, E., Khwaja, J., Rismani, A., Kyriakou, C., D’Sa, S.
Publicado 2022

P1112: TREATING BING-NEEL SYNDROME USING A TAILORED APPROACH: EXPERIENCE OF A SPECIALIST NEUROHAEMATOLOGY CLINIC

por Khwaja, J., Smyth, D., Rismani, A., Hoskote, C., Kyriakou, C., Lunn, M. P., D’Sa, S.
Publicado 2022

P1149: THE EVOLVING STATE OF PLAY IN 1000 PATIENTS WITH WALDENSTRÖM’S MACROGLOBULINAEMIA IN THE UNITED KINGDOM (UK): A REAL-WORLD DATA ANALYSIS FROM THE WMUK RORY MORRISON REGISTRY...

por Uppal, E., Otamas, A., Khwaja, J., McCarthy, H., Kothari, J., Rismani, A., El-Sharkawi, D., Kyriakou, C., D’Sa, S.
Publicado 2022

Prevalence and timing of TP53 mutations in del(17p) myeloma and effect on survival

por Chin, M, Sive, J I, Allen, C, Roddie, C, Chavda, S J, Smith, D, Blombery, P, Jones, K, Ryland, G L, Popat, R, Rismani, A, D'Sa, S, Rabin, N, Gale, R E, Yong, K L
Publicado 2017